Physician profile
Stephen A Rynick
NPI 1790721884
$11,815.98
in general payments reported to CMS, 2019-2025
22 companies · $983 in 2025
The $983 reported for 2025 was more than what 87% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $74.03 · 2021: $46.17 · 2022: $5,224 · 2023: $4,581 · 2024: $778 · 2025: $983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,250 · Food and Beverage: $1,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,250.00 |
| Food and Beverage | $1,092.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zentech INC. | $10,250.00 | 2022-2025 | |
| Abbott Laboratories | $579.99 | 2019-2025 | Proclaim, Eterna, Amplatzer Amulet |
| Medtronic, INC. | $211.02 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $173.68 | 2020-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Virtus Pharmaceuticals LLC | $119.56 | 2023-2025 | Levorphanol Tartrate |
| Spinal Simplicity, LLC | $77.43 | 2023-2025 | Ha Minuteman G3-R |
| Xtant Medical INC | $68.86 | 2024 | |
| Abbvie INC. | $50.81 | 2022-2025 | |
| Vertos Medical, INC. | $39.37 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $33.99 | 2023-2024 | Xtampza, Belbuca |
| Medtronic USA, INC. | $31.83 | 2019-2020 | |
| Nevro Corp. | $22.45 | 2019 | |
| Valinor Pharma, LLC | $21.15 | 2024 | Movantik |
| Nalu Medical, INC. | $18.84 | 2024 | Nalu Neurostimulation System |
| Ipsen Biopharmaceuticals, INC | $18.84 | 2023 | Dysport |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $17.84 | 2025 | Evoke |
| Vertiflex, INC. | $15.33 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.74 | 2024 | Relistor |
| Amgen INC. | $13.39 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.32 | 2021 | |
| Strongbridge US INC. | $12.27 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Rynick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.